Börsiteade
AS PRFoods
LEI kood
529900PFXFO2ZDCRNK93
Emitendi suuruskategooria
Keskmise suurusega kontsern
Majandustegevusalad
Finants- ja kindlustustegevus
Emitendi registreeritud asukoht
Eesti
Üldandmed
Kategooriad
Juhtkonna vaheteadaanne või kvartaalne finantsaruanne
Teate ID
10555
Manused
Esitamise kuupäev ja aeg
21.08.2023 08:30:00
Teate sisu eesti keeles
Pealkiri
AS-i PRFoods 2022/2023 majandusaasta 4. kvartali ja 12. kuu konsolideeritud auditeerimata vahearuanne
Teade
AS-i PRFoods 2022/2023 majandusaasta 4. kvartali ja 12. kuu konsolideeritud auditeerimata vahearuanne Esimene aasta täiesti muutunud ettevõttena on lõppenud mõningase eduga. PRFoods saavutas taas kasumlikkuse hoolimata väga suurest käibe vähenemisest. 4 kv käive oli 25% väiksem ja kogu aasta 53% vähem kui eelmistel perioodidel, kuna meil enam pole Rootsis ega Soomes ettevõtteid. Meie tegevuse kese on nüüd Suurbritannia ja Eesti kalakasvastus ja tootmine. Majandusaasta lõppes 19,6 miljoni euro suuruse käibega, võrreldes 42,1 miljonit eelmisel aastal, käibe langus oli eelarvestatud, arvestades, et grupp on oluliselt väiksem. Kõige olulisem - eelmise perioodi -1,6 miljonit ärikahjum vahetus 0,3 miljoni suuruseks ärikasumiks, paranemine 118.75%. PRFoodsi esimene puhaskasum mitme aasta jooksul oli 350,000 eurot ( eelmise aasta kahjum - 8,2 miljonit eurot). Kolmest üksusest kaks olid aasta baasil kasumis - kalakasvatus ja Suurbritannia, Eesti veel kahjumis. 4 kvartal on kalakasvatuses traditsiooniliset negatiivse tulemusega, kuna siis algab kasvatustega seotud kulude periood. Samuti oli 4 kvartalis kasumlikkus UK-s surve all tingituna äkiliselt lõhe hinna tõusust (mis tänaseks on taandunud). Meie tulemus olnuks parem, kui meie eksklusiivne edasimüüja Soomes poleks lõpetanud mai keskel koostööd. Lühiajaliselt on see tagasilöök, aga pikaajaliselt positiivne pööre, kuna me saame uuesti hakata Soome jaekettides otse müüma. . Alates 2024 pole meil enam konkurentsikeeldu Soomes ja me loodame juba esimesel aastal taastada müügid Soome mitme miljoni euro ulatuses. Kõrged toiduhinnad Eestis ja valitsuse plaan tõsta käibemaksu, mõjutab negatiivselt käibekasvu, tõstab inflatsiooni Eestis ning samuti Eesti tööstuste konkurentsivõimet. Ees on väljakutsed, aga uue juhtkonnaga olen veendunud, et saavutame kasumlikkuse ka Eesti tootmisüksuses järgmisel aastal. Ma olen väga rahul meie, et meie Suurbritannia üksus saavutas taas üle 1 miljoni euro suuruse tegevuskasumi (EBITDA), peale COVID kriisi ja nüüdset inflatsioonilist survet. John Ross Jr on jätkuvalt parimaid Shoti suitsutatud lõhe brände ja juhtkond on taas säranud. Mul on samuti hea meel teatada, et meie kasvatusluba Tagalahes, Saaremaal on kinnitatud ning hoonestusõiguse seadmine peaks toimuma septembris 2023, mis tähendab, et me saame tõsta oma kalakasvatuse mahte juba käesoleval majandusaastal Algava majandusaasta I kvartal on raske Eesti jaoks, Suurbritannia prognoos on lubav ja me ootame ajalooliselt parimat tulemust meie kalakasvatustelt. Rahavoo juhtimine on jätkuv väljakutse. Kahjuks pidime müüma oma kasumliku Rootsi kalakasvatuse tagastamaks pangalaenu, see üksus võimaldanuks grupil taastada oma kasumlikkus ning kasv palju kiiremini. Võlakordaja on endiselt liiga kõrge taastunud kasumlikkuse kohta ja aktsionäride jätkuv tugi on vajalik Elame huvitaval ajal, ning suures osas majandussektorites, ehk neis, mida riik ei subsideeri või kaitse, vahetub üks väljakutse teise vastu. VÕTMENÄITAJAD KASUMIARUANNE +----------------------+-------------+-------------+-------------+-------------+ |mln EUR | | | | | | | | | | | |v.a kui on näidatud | | | | | |teisiti |4kv 2022/2023|12k 2022/2023|4kv 2021/2022|12k 2021/2022| +----------------------+-------------+-------------+-------------+-------------+ |Müügitulu | 4,0| 19,6| 5,3| 42,1| +----------------------+-------------+-------------+-------------+-------------+ |Brutokasum | 0,4| 3,6| 0,5| 3,1| +----------------------+-------------+-------------+-------------+-------------+ |EBITDA äritegevusest | 0,1| 0,3| 0,4| -1,2| +----------------------+-------------+-------------+-------------+-------------+ |EBITDA | 0,1| 0,3| -0,3| -1,6| +----------------------+-------------+-------------+-------------+-------------+ |EBIT | -0,3| -1,0| -1,1| -4,2| +----------------------+-------------+-------------+-------------+-------------+ |EBT | -0,5| 0,4| -1,5| -8,2| +----------------------+-------------+-------------+-------------+-------------+ |Puhaskasum (-kahjum) | -0,5| 0,4| -1,5| -8,2| +----------------------+-------------+-------------+-------------+-------------+ |Brutomarginaal | 9,9%| 18,3%| 10,0%| 7,4%| +----------------------+-------------+-------------+-------------+-------------+ |Äritegevuse EBITDA | | | | | |marginaal | 2,3%| 1,6%| 7,6%| -2,8%| +----------------------+-------------+-------------+-------------+-------------+ |EBITDA marginaal | 2,3%| 1,6%| -6,3%| -3,7%| +----------------------+-------------+-------------+-------------+-------------+ |EBIT marginaal | -7,6%| -5,0%| -21,3%| -9,9%| +----------------------+-------------+-------------+-------------+-------------+ |EBT marginaal | -12,7%| 2,2%| -28,7%| -19,5%| +----------------------+-------------+-------------+-------------+-------------+ |Puhaskasumi marginaal | -12,3%| 1,8%| -29,0%| -19,4%| +----------------------+-------------+-------------+-------------+-------------+ |Tegevuskulude suhtarv | -21,3%| -24,0%| -25,8%| -17,1%| +----------------------+-------------+-------------+-------------+-------------+ BILANSS +-------------------------------+------------+------------+------------+ | mln EUR | | | | | v.a kui on näidatud teisiti | 30.06.2023 | 30.06.2022 | 30.06.2021 | +-------------------------------+------------+------------+------------+ | Netovõlgnevus | 16,9 | 24,7 | 22,4 | +-------------------------------+------------+------------+------------+ | Omakapital | 7,5 | 8,1 | 15,8 | +-------------------------------+------------+------------+------------+ | Käibekapital | 0,3 | -3,2 | -3,2 | +-------------------------------+------------+------------+------------+ | Varad | 29,9 | 38,9 | 55,6 | +-------------------------------+------------+------------+------------+ | Likviidsuskordaja | 1,1x | 0,7x | 0,8x | +-------------------------------+------------+------------+------------+ | Omakapitali suhtarv | 25,1% | 20,7% | 28,4% | +-------------------------------+------------+------------+------------+ | Finantsvõimendus | 69,2% | 75,4% | 58,7% | +-------------------------------+------------+------------+------------+ | Võlakordaja | 0,7x | 0,8x | 0,7x | +-------------------------------+------------+------------+------------+ | Netovõlg / äritegevuse EBITDA | 54,9x | -14,5x | -17,9x | +-------------------------------+------------+------------+------------+ | Omakapitali tootlus | 4,4% | -68,5% | -29,0% | +-------------------------------+------------+------------+------------+ | Varade tootlus | 1,0% | -17,3% | -9,2% | +-------------------------------+------------+------------+------------+ Konsolideeritud finantsseisundi aruanne +-------------------------------------+------------+------------+ | EUR '000 | 30.06.2023 | 30.06.2022 | +-------------------------------------+------------+------------+ | VARAD | | | +-------------------------------------+------------+------------+ | Raha ja ekvivalendid | 394 | 110 | +-------------------------------------+------------+------------+ | Nõuded ja ettemaksed | 2 168 | 2 567 | +-------------------------------------+------------+------------+ | Varud | 1 861 | 2 196 | +-------------------------------------+------------+------------+ | Bioloogilised varad | 772 | 3 003 | +-------------------------------------+------------+------------+ | Käibevara kokku | 5 195 | 7 876 | +-------------------------------------+------------+------------+ | | | | +-------------------------------------+------------+------------+ | Edasilükkunud tulumaksuvara | - | 93 | +-------------------------------------+------------+------------+ | Pikaajalised finantsinvesteeringud | 381 | 229 | +-------------------------------------+------------+------------+ | Materiaalne põhivara | 6 563 | 8 882 | +-------------------------------------+------------+------------+ | Immateriaalne vara | 17 718 | 21 837 | +-------------------------------------+------------+------------+ | Põhivara kokku | 24 662 | 31 041 | +-------------------------------------+------------+------------+ | VARAD KOKKU | 29 857 | 38 917 | +-------------------------------------+------------+------------+ | | | | +-------------------------------------+------------+------------+ | KOHUSTUSED JA OMAKAPITAL | | | +-------------------------------------+------------+------------+ | Intressikandvad kohustused | 1 793 | 7 094 | +-------------------------------------+------------+------------+ | Võlad ja ettemaksed | 3 127 | 3 978 | +-------------------------------------+------------+------------+ | Lühiajalised kohustused kokku | 4 919 | 11 073 | +-------------------------------------+------------+------------+ | | | | +-------------------------------------+------------+------------+ | Intressikandvad kohustused | 15 461 | 17 725 | +-------------------------------------+------------+------------+ | Võlad ja ettemaksed | - | 204 | +-------------------------------------+------------+------------+ | Edasilükkunud tulumaksukohustus | 1 664 | 1 599 | +-------------------------------------+------------+------------+ | Sihtfinantseerimine | 318 | 265 | +-------------------------------------+------------+------------+ | Pikaajalised kohustused kokku | 17 442 | 19 792 | +-------------------------------------+------------+------------+ | KOHUSTUSED KOKKU | 22 361 | 30 865 | +-------------------------------------+------------+------------+ | | | | +-------------------------------------+------------+------------+ | Aktsiakapital | 7 737 | 7 737 | +-------------------------------------+------------+------------+ | Ülekurss | 14 007 | 14 007 | +-------------------------------------+------------+------------+ | Oma aktsiad | - 390 | - 390 | +-------------------------------------+------------+------------+ | Kohustuslik reservkapital | 51 | 51 | +-------------------------------------+------------+------------+ | Realiseerimata kursivahed | 549 | 839 | +-------------------------------------+------------+------------+ | Jaotamata kasum (kahjum) | -14 719 | - 14 391 | +-------------------------------------+------------+------------+ | Ettevõtte aktsionäridele kuuluv osa | 7 236 | 7 853 | +-------------------------------------+------------+------------+ | Mittekontrolliv osalus | 259 | 199 | +-------------------------------------+------------+------------+ | OMAKAPITAL KOKKU | 7 495 | 8 052 | +-------------------------------------+------------+------------+ | OMAKAPITAL JA KOHUSTUSED KOKKU | 29 857 | 38 917 | +-------------------------------------+------------+------------+ Konsolideeritud koondkasumiaruanne +--------------------------------------+---------+---------+---------+---------+ | | 4kv| 4kv| 12k| 12k| |EUR '000 |2022/2023|2021/2022|2022/2023|2021/2022| +--------------------------------------+---------+---------+---------+---------+ |Müügitulud | 3 993| 5 250| 19 578| 42 128| +--------------------------------------+---------+---------+---------+---------+ |Müüdud kaupade kulu | -3 599| -4 723| -16 003| -38 993| +--------------------------------------+---------+---------+---------+---------+ |Brutokasum | 394| 528| 3 575| 3 136| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Tegevuskulud | -851| -1 354| -4 706| -7 207| +--------------------------------------+---------+---------+---------+---------+ |Müügi- ja turustuskulud | -755| -630| -2 691| -4 843| +--------------------------------------+---------+---------+---------+---------+ |Üldhalduskulud | -96| -724| -2 015| -2 364| +--------------------------------------+---------+---------+---------+---------+ |Muud äritulud/-kulud | 152| 443| 150| 307| +--------------------------------------+---------+---------+---------+---------+ |Bioloogiliste varade ümberhindlus | 0| -734| 0| -420| +--------------------------------------+---------+---------+---------+---------+ |Ärikasum (-kahjum) | -305| -1 117| -982| -4 184| +--------------------------------------+---------+---------+---------+---------+ |Finantstulud/-kulud | -203| -388| 1 416| 4 039| +--------------------------------------+---------+---------+---------+---------+ |Maksustamiseelne kasum (kahjum) | -508| -1 505| 434| -8 223| +--------------------------------------+---------+---------+---------+---------+ |Tulumaks | 19| -20| 87| 63| +--------------------------------------+---------+---------+---------+---------+ |Aruandeperioodi puhaskasum (-kahjum) | -489| -1 525| 347| -8 160| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Aruandeperioodi puhaskasumi (-kahjumi)| | | | | |jaotus: | | | | | +--------------------------------------+---------+---------+---------+---------+ |Emaettevõtte aktsionäridele kuuluv osa| -503| -1 502| 319| -8 143| +--------------------------------------+---------+---------+---------+---------+ |Mittekontrolliv osalus | 13| -23| 28| -17| +--------------------------------------+---------+---------+---------+---------+ |Aruandeperioodi puhaskasum (-kahjum) | | | | | |kokku | -489| -1 525| 347| -8 160| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Muu koondkasum (-kahjum), mida võib | | | | | |hiljem klassifitseerida | | | | | |kasumiaruandesse: | | | | | +--------------------------------------+---------+---------+---------+---------+ |Valuutakursi vahed | 288| 148| -290| 280| +--------------------------------------+---------+---------+---------+---------+ |Kokku koondkasum (-kahjum) | -201| -1 377| 57| -7 880| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Aruandeperioodi koondkasumi (-kahjumi)| | | | | |jaotus: | | | | | +--------------------------------------+---------+---------+---------+---------+ |Emaettevõtte aktsionäridele kuuluv osa| -215| -1 354| 29| -7 863| +--------------------------------------+---------+---------+---------+---------+ |Väikeaktsionäridele kuuluv osa | 13| -23| 28| -17| +--------------------------------------+---------+---------+---------+---------+ |Aruandeperioodi koondkasum (-kahjum) | | | | | |kokku | -201| -1 377| 57| -7 880| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Tava puhaskasum (-kahjum) aktsia kohta| | | | | |(EUR) | -0,01| -0,04| 0,01| -0,21| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Lahustatud puhaskasum (-kahjum) aktsia| | | | | |kohta (EUR) | -0,01| -0,03| 0,01| -0,21| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ Indrek Kasela AS PRFoods Juhatuse liige T: +372 452 1470 [email protected] www.prfoods.ee
Teate sisu inglise keeles
Pealkiri
Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year
Teade
Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2022/2023 financial year First year as fully transformed company has ended with moderate success. PRFoods regained profitability despite significantly lower revenues. Q4 revenues were less by 25% and full year by 53%, since we no longer have our Swedish or Finnish operations. Center of our operations is now UK and Estonian fish processing and farming. We ended full year with 19,6 million Euro sales compared to 42,1 million last year, but more importantly, our previous year -1,6 million EBITDA loss was replaced with 0,3 million Euro profit, 118,75% improvement. PRFoods first net profit in many years was 350,000 Euros (last year - 8,2 million loss). Two out of three of our operations: fish farming, Estonian processing and UK and fish farming were profitable. Estonian processing unit posted loss. Our result could have been even better, but our exclusive seller in Finland decided to end the co-operation in May. While in short term it causes pain, in long term this will benefit us handsomely, since from 2024 we no longer are prohibited by non-competition in Finland, can sell directly to retailers and hope to regain several million Euros in sales already in 2024. High food prices in Estonia and governments plan to raise VAT will dampen demand in Estonia, rise inflation and also affect the competitiveness of Estonian industries. It is a challenge, but with new management in helm at Estonia, I am fully confident that Estonian processing operations will also be profitable next year. I am extremely pleased that our UK business reached over 1 million Euros Ebitda again, after COVID crisis and now inflationary pressures. John Ross Jr continues to be best Scottish smoked salmon brand and the management has excelled again. I am also very pleased to announce that our new fish farming licence application in Estonia has been approved and we expect to get the water usage permit in September 2023, meaning we can scale up our fish farming production already from 2024. Q1 of current year is tough still for Estonia, UK forecast is promising and we expect historically best result from fish farming unit. Cashflow management remains a challenge. Unfortunately we were forced to sell off our profitable Swedish unit to fully repay group level bank loan, this unit could have helped us to regain profitability much faster at much higher level. Leverage is still too high for regained profitability and additional support from shareholders is needed. We live in interesting times, and one challenge is replaced by another for most of the industries that are not protected or subsidised by government. KEY RATIOS INCOME STATEMENT +------------------+------------+----------------+------------+----------------+ |mln EUR | | | | | |(unless indicated | | | | | |otherwise) |4Q 2022/2023|12 mos 2021/2022|4Q 2021/2022|12 mos 2020/2021| +------------------+------------+----------------+------------+----------------+ |Sales | 4,0| 19,6| 5,3| 42,1| +------------------+------------+----------------+------------+----------------+ |Gross profit | 0,4| 3,6| 0,5| 3,1| +------------------+------------+----------------+------------+----------------+ |EBITDA from | | | | | |operations | 0,1| 0,3| 0,4| -1,2| +------------------+------------+----------------+------------+----------------+ |EBITDA | 0,1| 0,3| -0,3| -1,6| +------------------+------------+----------------+------------+----------------+ |EBIT | -0,3| -1,0| -1,1| -4,2| +------------------+------------+----------------+------------+----------------+ |EBT | -0,5| 0,4| -1,5| -8,2| +------------------+------------+----------------+------------+----------------+ |Net profit (loss) | -0,5| 0,35| -1,5| -8,2| +------------------+------------+----------------+------------+----------------+ |Gross margin | 9,9%| 18,3%| 10,0%| 7,4%| +------------------+------------+----------------+------------+----------------+ |Operational EBITDA| | | | | |margin | 2,3%| 1,6%| 7,6%| -2,8%| +------------------+------------+----------------+------------+----------------+ |EBITDA margin | 2,3%| 1,6%| -6,3%| -3,7%| +------------------+------------+----------------+------------+----------------+ |EBIT margin | -7,6%| -5,0%| -21,3%| -9,9%| +------------------+------------+----------------+------------+----------------+ |EBT margin | -12,7%| 2,2%| -28,7%| -19,5%| +------------------+------------+----------------+------------+----------------+ |Net margin | -12,3%| 1,8%| -29,0%| -19,4%| +------------------+------------+----------------+------------+----------------+ |Operating expense | | | | | |ratio | -21,3%| -24,0%| -25,8%| -17,1%| +------------------+------------+----------------+------------+----------------+ BALANCE SHEET +------------------------------+------------+------------+------------+ | mln EUR | | | | | unless indicated otherwise | 30.06.2023 | 30.06.2022 | 30.06.2021 | +------------------------------+------------+------------+------------+ | Net debt | 16,9 | 24,7 | 22,4 | +------------------------------+------------+------------+------------+ | Equity | 7,5 | 8,1 | 15,8 | +------------------------------+------------+------------+------------+ | Working capital | 0,3 | -3,2 | -3,2 | +------------------------------+------------+------------+------------+ | Assets | 29,9 | 38,9 | 55,6 | +------------------------------+------------+------------+------------+ | Liquidity ratio | 1,1x | 0,7x | 0,8x | +------------------------------+------------+------------+------------+ | Equity ratio | 25,1% | 20,7% | 28,4% | +------------------------------+------------+------------+------------+ | Gearing ratio | 69,2% | 75,4% | 58,7% | +------------------------------+------------+------------+------------+ | Debt to total assets | 0,7x | 0,8x | 0,7x | +------------------------------+------------+------------+------------+ | Net debt to operating EBITDA | 54,9x | -14,5x | -17,9x | +------------------------------+------------+------------+------------+ | ROE | 4,4% | -68,5% | -29,0% | +------------------------------+------------+------------+------------+ | ROA | 1,0% | -17,3% | -9,2% | +------------------------------+------------+------------+------------+ Consolidated Statement of Financial Position +----------------------------------+------------+------------+ | EUR '000 | 30.06.2023 | 30.06.2022 | +----------------------------------+------------+------------+ | ASSETS | | | +----------------------------------+------------+------------+ | Cash and cash equivalents | 394 | 110 | +----------------------------------+------------+------------+ | Receivables and prepayments | 2 168 | 2 567 | +----------------------------------+------------+------------+ | Inventories | 1 861 | 2 196 | +----------------------------------+------------+------------+ | Biological assets | 772 | 3 003 | +----------------------------------+------------+------------+ | Total current assets | 5 195 | 7 876 | +----------------------------------+------------+------------+ | | | | +----------------------------------+------------+------------+ | Deferred tax assets | - | 93 | +----------------------------------+------------+------------+ | Long-term financial investments | 381 | 229 | +----------------------------------+------------+------------+ | Tangible assets | 6 563 | 8 882 | +----------------------------------+------------+------------+ | Intangible assets | 17 718 | 21 837 | +----------------------------------+------------+------------+ | Total non-current assets | 24 662 | 31 041 | +----------------------------------+------------+------------+ | TOTAL ASSETS | 29 857 | 38 917 | +----------------------------------+------------+------------+ | | | | +----------------------------------+------------+------------+ | EQUITY AND LIABILITIES | | | +----------------------------------+------------+------------+ | Interest-bearing liabilities | 1 793 | 7 094 | +----------------------------------+------------+------------+ | Payables and prepayments | 3 127 | 3 978 | +----------------------------------+------------+------------+ | Total current liabilities | 4 919 | 11 073 | +----------------------------------+------------+------------+ | | | | +----------------------------------+------------+------------+ | Interest-bearing liabilities | 15 461 | 17 725 | +----------------------------------+------------+------------+ | Payables and prepayments | - | 204 | +----------------------------------+------------+------------+ | Deferred tax liabilities | 1 664 | 1 599 | +----------------------------------+------------+------------+ | Government grants | 318 | 265 | +----------------------------------+------------+------------+ | Total non-current liabilities | 17 442 | 19 792 | +----------------------------------+------------+------------+ | TOTAL LIABILITIES | 22 361 | 30 865 | +----------------------------------+------------+------------+ | | | | +----------------------------------+------------+------------+ | Share capital | 7 737 | 7 737 | +----------------------------------+------------+------------+ | Share premium | 14 007 | 14 007 | +----------------------------------+------------+------------+ | Treasury shares | - 390 | - 390 | +----------------------------------+------------+------------+ | Statutory capital reserve | 51 | 51 | +----------------------------------+------------+------------+ | Currency translation differences | 549 | 839 | +----------------------------------+------------+------------+ | Retained profit (loss) | -14 719 | - 14 391 | +----------------------------------+------------+------------+ | Equity attributable to parent | 7 236 | 7 853 | +----------------------------------+------------+------------+ | Non-controlling interest | 259 | 199 | +----------------------------------+------------+------------+ | TOTAL EQUITY | 7 495 | 8 052 | +----------------------------------+------------+------------+ | TOTAL EQUITY AND LIABILITIES | 29 857 | 38 917 | +----------------------------------+------------+------------+ Consolidated Statement of Profit or Loss And Other Comprehensive Income +--------------------------------------+---------+---------+---------+---------+ | | 4Q| 4Q| 12m| 12m| |EUR '000 |2022/2023|2021/2022|2022/2023|2021/2022| +--------------------------------------+---------+---------+---------+---------+ |Revenue | 3 993| 5 250| 19 578| 42 128| +--------------------------------------+---------+---------+---------+---------+ |Cost of goods sold | -3 599| -4 723| -16 003| -38 993| +--------------------------------------+---------+---------+---------+---------+ |Gross profit | 394| 528| 3 575| 3 136| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Operating expenses | -851| -1 354| -4 706| -7 207| +--------------------------------------+---------+---------+---------+---------+ |Selling and distribution expenses | -755| -630| -2 691| -4 843| +--------------------------------------+---------+---------+---------+---------+ |Administrative expenses | -96| -724| -2 015| -2 364| +--------------------------------------+---------+---------+---------+---------+ |Other income / expense | 152| 443| 150| 307| +--------------------------------------+---------+---------+---------+---------+ |Fair value adjustment on biological | | | | | |assets | 0| -734| 0| -420| +--------------------------------------+---------+---------+---------+---------+ |Operating profit (loss) | -305| -1 117| -982| -4 184| +--------------------------------------+---------+---------+---------+---------+ |Financial income / expenses | -203| -388| 1 416| 4 039| +--------------------------------------+---------+---------+---------+---------+ |Profit (Loss) before tax | -508| -1 505| 434| -8 223| +--------------------------------------+---------+---------+---------+---------+ |Income tax | 19| -20| 87| 63| +--------------------------------------+---------+---------+---------+---------+ |Net profit (loss) for the period | -489| -1 525| 347| -8 160| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Net profit (loss) attributable to: | | | | | +--------------------------------------+---------+---------+---------+---------+ |Owners of the Parent Company | -503| -1 502| 319| -8 143| +--------------------------------------+---------+---------+---------+---------+ |Non-controlling interests | 13| -23| 28| -17| +--------------------------------------+---------+---------+---------+---------+ |Total net profit (loss) for the period| -489| -1 525| 347| -8 160| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Other comprehensive income (loss) that| | | | | |may subsequently be classified to | | | | | |profit or loss: | | | | | +--------------------------------------+---------+---------+---------+---------+ | Foreign currency translation | | | | | | differences | 288| 148| -290| 280| +--------------------------------------+---------+---------+---------+---------+ |Total comprehensive income | | | | | |(expense) | -201| -1 377| 57| -7 880| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Total comprehensive income (expense) | | | | | |attributable to: | | | | | +--------------------------------------+---------+---------+---------+---------+ |Owners of the Parent Company | -215| -1 354| 29| -7 863| +--------------------------------------+---------+---------+---------+---------+ |Non-controlling interests | 13| -23| 28| -17| +--------------------------------------+---------+---------+---------+---------+ |Total comprehensive income | | | | | |(expense) for the period | -201| -1 377| 57| -7 880| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Profit (Loss) per share (EUR) | -0,01| -0,04| 0,01| -0,21| +--------------------------------------+---------+---------+---------+---------+ | | | | | | +--------------------------------------+---------+---------+---------+---------+ |Diluted profit (loss) per share (EUR) | -0,01| -0,03| 0,01| -0,21| +--------------------------------------+---------+---------+---------+---------+ Indrek Kasela AS PRFoods Member of the Management Board Phone:+372 452 1470 [email protected] www.prfoods.ee